Awerbach, J. D., Fathallah, M., Serfas, J., Cappiello, J., Oberti, C., Parikh, K. S., … Krasuski, R. (2019). Inhaled Iloprost for Vasoreactivity Assessment in Patients With Pulmonary Hypertension: Preliminary Results From the OVATION Study (NCT03044314). In CIRCULATION (Vol. 140).

Awerbach, Jordan D., Mouhammad Fathallah, John Serfas, Jhaymie Cappiello, Carlos Oberti, Kishan S. Parikh, Fortin Terry, Sudar Rajagopal, Talal Dahhan, and Richard Krasuski. “Inhaled Iloprost for Vasoreactivity Assessment in Patients With Pulmonary Hypertension: Preliminary Results From the OVATION Study (NCT03044314).” In CIRCULATION, Vol. 140, 2019.

Awerbach JD, Fathallah M, Serfas J, Cappiello J, Oberti C, Parikh KS, et al. Inhaled Iloprost for Vasoreactivity Assessment in Patients With Pulmonary Hypertension: Preliminary Results From the OVATION Study (NCT03044314). In: CIRCULATION. 2019.

Awerbach, Jordan D., et al. “Inhaled Iloprost for Vasoreactivity Assessment in Patients With Pulmonary Hypertension: Preliminary Results From the OVATION Study (NCT03044314).” CIRCULATION, vol. 140, 2019.

Awerbach JD, Fathallah M, Serfas J, Cappiello J, Oberti C, Parikh KS, Terry F, Rajagopal S, Dahhan T, Krasuski R. Inhaled Iloprost for Vasoreactivity Assessment in Patients With Pulmonary Hypertension: Preliminary Results From the OVATION Study (NCT03044314). CIRCULATION. 2019.